Pathology
 |
|
19 september 2019 18:01:22 |
| Abicipar pegol--a novel anti-VEGF therapy with a long duration of action (Eye) |
|
Tweet |
| 190 viewsCategory: Neurology, Pathology |
 Brolucizimab--leading an era of structural revolution for long-term VEGF suppression (Eye)The impact of artificial intelligence in the diagnosis and management of glaucoma (Eye) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
